Genentech’s Vabysmo Well-Received Amongst Ophthalmologists, but Use Continues to Lag the Competition, According to Spherix Global Insights

Despite a very satisfied Vabysmo user-base, Regeneron’s 8mg aflibercept is already highly anticipated by ophthalmologists and likely to throw a wrench into Vabysmo’s positive trajectory. EXTON, Pa., March 29, 2023 /PRNewswire/ — According to Spherix Global Insights’ Launch Dynamix™:…